Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): Kinetics and biochemical response in estrogenized osteoporotic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 6, 1993, Pages 1535-1539

  Lindsay, R ^a,b   Nieves, J ^a   Henneman, E ^a   Shen, V ^a   Cosman, F ^a,b  

^a HELEN HAYES HOSPITAL   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CYCLIC AMP; ESTROGEN; PARATHYROID HORMONE[1-34]; PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLEARANCE; CLINICAL ARTICLE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HALF LIFE TIME; HUMAN; KIDNEY; MINERAL BALANCE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; SKELETON; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

CALCITRIOL; CALCIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; INJECTIONS, SUBCUTANEOUS; MIDDLE AGE; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONES; PEPTIDE FRAGMENTS; PHOSPHATES; SUPPORT, U.S. GOV'T, P.H.S.; TERIPARATIDE;

EID: 0027132484     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.6.8263137     Document Type: Article

References (23)

1. Selye H. 1932 On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology. 16:547-558.
2. Reeve J, Hesp R, Williams D, et al. 1976 Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet. 1:1035-1038.
3. Reeve J, Tregear GW, Parsons JA. 1976 Preliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis. Calcif Tissue. 21:469-477.
4. Reeve J, Meunier P, Parsons JA, et al. 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J. 1340-1344.
5. Slovik DM, Neer RM, Potts Jr JT. 1981 Short-term effects of synthetic human parathyroid hormone (1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest. 68:1261-1271.
6. Slovik DM, Adams JS, Neer RM, et al. 1981 Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med. 305:372-374.
7. Tsai K, Heath III HH, Kumar R, et al. 1984 Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest. 73:1668-1672.
8. Slovik DM, Rosenthal DI, Doppelt JH, et al. 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Mineral Res. 1:377-381.
9. Neer RM, Slovik D, Doppelt S, et al. 1987 The use of parathyroid hormone plus 1,25-dihhydroxyvitamin D to increase trabecular bone in osteoporotic men and postmenopausal women. In: Christiansen C, Johansen JS, Riis BJ, eds. Osteoporosis. Copenhagen: Osteopress; 829-835.
10. Cosman F, Shen V, Herrington BS, et al. 1990 Mechanism of estrogen action in osteoporosis treatment as assessed by human (1-34)PTH infusion. In: Christiansen C, Overgaard K. eds. Osteoporosis III. Copenhagen: Osteopress; 976-978.
11. Riggs BL, Hamstra A, DeLuca HF. 1981 Assessment of 25-hydroxy-vitamin D 1-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract. J Clin Endocrinol Metab. 53:833-835.
12. Sorenson OH, Lumholtz B, Lund B, et al. 1981 Acute effects of parathyroid hormone on vitamin D metabolism in patients with the bone loss of aging. J Clin Endocrinol Metab. 54:1258-1261.
13. Cosman F, Shen V, Herrington BS, et al. 1991 Response of the parathyroid gland to infusion of (l-34)hPTH: demonstration of suppression of endogenous secretion using IRMA intact (1-84)PTH assay. J Clin Endocrinol Metab. 73:1345-1351.
14. Reeve J, Davies UM, Hesp R, et al. 1990 Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Br Med J. 30:314-318.
15. Kent GN, Loveridge N, Reeve J, et al. 1985 Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay. Clin Sri. 68:171-177.
16. Segre GV. 1983 Amino terminal radioimmunoassays for human PTH. In: Frame B, Potts Jr JT, eds. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica; 14.
17. Preece MAA, O'Riordan JLH, Lawson DEM, et al. 1974 An assay for 25-dydroxycholecalriferol and 25 hydroxyergocalriferol in serum. Clin Chim Acta. 54:235-242.
18. Reinhardt TA, Horst RL, Orf JW, et al. 1984 A microassay for dihydroxyvitamin D not requiring HPLC: application to clinical studies. J Clin Endocrinol Metab. 58:91-98.
19. Kraegen EW, Chisholm DJ. 1984 Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies. Diabetologia. 26:208-213.
20. Markowitz ME, Arnaud S, Rosen JF, et al. 1988 Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations. J Clin Endocrinol Metab. 67:1068-1073.
21. Calvo MS, Eastell R, Offord KP, et al. 1991 Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab. 72:6876.
22. Silver J. 1993 Regulation of parathyroid hormone synthesis and secretion. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven Press; 83-106.
23. Fujimi T, Baba H, Fukase M, et al. 1991 Direct inhibitory effect of amino-terminal parathyroid hormone fragment [PTH(1-34)J on PTHh secretion from bovine parathyroid primary cultured cells in vitro. Biochem Biophys Res Commun. 178:953-958.